Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Abiraterone acetate plus prednisolone added to ADT + docetaxel, gives 25% reduction in risk of death compared to ADT + docetaxel alone in prostate cancer

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
Abiraterone acetate plus prednisolone added to ADT + docetaxel, gives 25% reduction in risk of death compared to ADT + docetaxel alone in prostate cancer ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
19 Sep 2021

Impact of cytogenetic abnormalities on treatment outcomes in patients with AL amyloidosis

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
Impact of cytogenetic abnormalities on treatment outcomes in patients with AL amyloidosis ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
19 Sep 2021

Impact of biomarkers on pCR and survival after T-DM1 with or without ET vs trastuzumab and ET in HER2/HR positive early BC

Prof Nadia Harbeck - University of Munich, Munich, Germany
Impact of biomarkers on pCR and survival after T-DM1 with or without ET vs trastuzumab and ET in HER2/HR positive early BC ( Prof Nadia Harbeck - University of Munich, Munich, Germany )
18 Sep 2021

Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer

Prof Bradley Monk - University of Arizona College of Medicine, Phoenix, USA
Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer ( Prof Bradley Monk - University of Arizona College of Medicine, Phoenix, USA )
18 Sep 2021

6 months trastuzumab non-inferior to 12 months for HER2 positive early breast cancer

Prof Helena Earl - University of Cambridge, Cambridge, United Kingdom
6 months trastuzumab non-inferior to 12 months for HER2 positive early breast cancer ( Prof Helena Earl - University of Cambridge, Cambridge, United Kingdom )
17 Sep 2021

Multidisciplinary management of ovarian germ cell tumours - a single institutional study from India

Dr Sandip Ganguly - Tata Medical Center, Kolkata, India
Multidisciplinary management of ovarian germ cell tumours - a single institutional study from India ( Dr Sandip Ganguly - Tata Medical Center, Kolkata, India )
14 Sep 2021

Suboptimal humoral immune response to COVID-19 vaccination in myeloma patients

Dr Oliver Van Oekelen - Icahn School of Medicine at Mount Sinai, New York City, USA
Suboptimal humoral immune response to COVID-19 vaccination in myeloma patients ( Dr Oliver Van Oekelen - Icahn School of Medicine at Mount Sinai, New York City, USA )
10 Sep 2021

Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy

Dr Oliver Van Oekelen - Icahn School of Medicine at Mount Sinai, New York City, USA
Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy ( Dr Oliver Van Oekelen - Icahn School of Medicine at Mount Sinai, New York City, USA )
10 Sep 2021

Retrospective analysis of COVID-19 infection in 371 Czech multiple myeloma patients

Dr Jakub Radocha - Charles University, Hradec Kralove, Czech Republic
Retrospective analysis of COVID-19 infection in 371 Czech multiple myeloma patients ( Dr Jakub Radocha - Charles University, Hradec Kralove, Czech Republic )
10 Sep 2021

OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
31 Aug 2021

OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Aug 2021

OncoAlert and ecancer weekly round up for July 26 - August 1, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for July 26 - August 1, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
2 Aug 2021